Figure 7
Figure 7. The expression of Tyk2 in DCs is required for in vivo priming of Th1 cells. DO11.10+ CD4+ T cells (1 × 106 cells/mouse) were injected intraperitoneally into recipient BALB/c mice. Two days later, OVA323–339–pulsed WT or Tyk2−/− CD11c+ DCs (3.5 × 105 cells/mouse) were injected into footpad of the recipient mice. Five days later, popliteal lymph node cells were harvested from the recipient mice and cultured with OVA323–339–pulsed WT CD11c+ DCs at the indicated ratios for 96 hours. The amounts of IL-4 and IFN-γ in the supernatants were measured by ELISA. Data are means (± SD) from 4 independent experiments. *P < .05.

The expression of Tyk2 in DCs is required for in vivo priming of Th1 cells. DO11.10+ CD4+ T cells (1 × 106 cells/mouse) were injected intraperitoneally into recipient BALB/c mice. Two days later, OVA323–339–pulsed WT or Tyk2−/− CD11c+ DCs (3.5 × 105 cells/mouse) were injected into footpad of the recipient mice. Five days later, popliteal lymph node cells were harvested from the recipient mice and cultured with OVA323–339–pulsed WT CD11c+ DCs at the indicated ratios for 96 hours. The amounts of IL-4 and IFN-γ in the supernatants were measured by ELISA. Data are means (± SD) from 4 independent experiments. *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal